STOCK TITAN

DNP Select Income Fund Inc. Form 4 Filings

DNP NYSE

Every Form 4 that DNP Select Income Fund Inc. (DNP) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A Form 4 covers the transactions officers, directors and large holders report, so if you follow DNP and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full DNP filings page.

Rhea-AI Summary

MetLife Investment Management, LLC, a 10% owner of DNP Select Income Fund Inc., reported indirect dispositions of an aggregate 80,100,000 principal amount of 3.00% Series B Senior Secured Notes due July 22, 2026. The notes matured on July 22, 2026, when the issuer agreed to repay the original principal plus accrued and unpaid interest. The notes were held directly by MetLife-managed clients, and MetLife Investment Management disclaims beneficial ownership except to the extent of its pecuniary interest.

Rhea-AI Summary

Corebridge Financial, Inc. reported disposition transactions in this Form 4 filing.

Corebridge Financial, Inc., as reporting person for DNP Select Income Fund Inc., reports that its subsidiaries’ holdings of 3.00% Series B Senior Secured Notes were fully redeemed at maturity by the issuer for 100% of the aggregate principal amount plus accrued and unpaid interest. American General Life Insurance Company held $15,000,000.00 principal amount and The Variable Annuity Life Insurance Company held $18,000,000.00 principal amount of these notes. Corebridge’s subsidiaries also continue to indirectly hold 660 Series E Mandatory Redeemable Preferred Shares, allocated among three insurance subsidiaries.

Rhea-AI Summary

DNP Select Income Fund director Mark G. Kahrer bought 20,000 shares of common stock in an open-market transaction at $10.21 per share on February 11, 2026. Following this purchase, he directly owns 23,000 DNP shares. The transaction was reported as a routine Form 4 insider purchase.